Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

6.17
Delayed Data
As of Jun 24
 -0.05 / -0.80%
Today’s Change
5.93
Today|||52-Week Range
9.51
-23.35%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close6.22
Today’s open6.17
Day’s range6.17 - 6.25
Volume1,516
Average volume (3 months)5,962
Market cap$157.0M
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.24
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
PIPPharmAthene Inc+0.05+2.14%
AKTXAkari Therapeutics P...-0.61-4.34%
CYTRCytRx Corp-0.02-0.84%
OVASOvaScience Inc-0.32-5.97%
Data as of 06/24/2016

Financials

Next reporting dateAugust 17, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Assaf Kacen
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers

Search for Jobs